Assembly Biosciences, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Assembly Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $0.00.
- Assembly Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $0.00.
- Assembly Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $0.00.
- Assembly Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $1.92M.
- Assembly Biosciences, Inc. stock issued during period, value, new issues for fiscal 2025 was $1.92M, a 5.32% decline from fiscal 2024.
- Assembly Biosciences, Inc. stock issued during period, value, new issues for fiscal 2024 was $2.03M, a 55.35% decline from fiscal 2023.
- Assembly Biosciences, Inc. stock issued during period, value, new issues for fiscal 2023 was $4.55M, a 1298.77% increase from fiscal 2022.
- Assembly Biosciences, Inc. stock issued during period, value, new issues for fiscal 2022 was $325.00K, a 99.38% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $1.92M 10-K · filed 2026-03-19 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | |
| 2025-03-31 | $1.92M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $2.03M 10-K · filed 2026-03-19 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $4.55M 10-K · filed 2025-03-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | |
| 2023-06-30 | $54.00K 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $4.49M 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $325.00K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $52.81M 10-K · filed 2023-03-22 |
| 2021-09-30 | $10.05M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $6.01M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $34.14M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $5.45M 10-K · filed 2022-03-11 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $155.43M 10-K · filed 2021-02-25 |
| 2018-09-30 | $155.43M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $64.85M 10-K · filed 2020-03-04 | |
| 2013-12-31 | $19.20M 10-K · filed 2014-03-31 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $4.17M 10-K · filed 2013-03-18 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | |
| 2011-09-30 | $1.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-18 | |
| 2008-12-31 | $929.46K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |